S.2516 - Food and Drug Administration Safety and Innovation Act

An original bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. view all titles (11)

All Bill Titles

  • Official: An original bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. as introduced.
  • Short: Food and Drug Administration Safety and Innovation Act as introduced.
  • Short: Biosimilar User Fee Act of 2012 as introduced.
  • Short: Generic Drug User Fee Amendments of 2012 as introduced.
  • Short: Medical Device User Fee Amendments of 2012 as introduced.
  • Short: Prescription Drug User Fee Amendments of 2012 as introduced.
  • Short: Food and Drug Administration Safety and Innovation Act as reported to senate.
  • Short: Biosimilar User Fee Act of 2012 as reported to senate.
  • Short: Generic Drug User Fee Amendments of 2012 as reported to senate.
  • Short: Medical Device User Fee Amendments of 2012 as reported to senate.
  • Short: Prescription Drug User Fee Amendments of 2012 as reported to senate.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

Comments Feed

No Comments Start the Conversation!


Vote on This Bill

100% Users Support Bill

1 in favor / 0 opposed
 

Send Your Senator a Letter

about this bill Support Oppose Tracking
Track with MyOC